The WHO will not recommend remdesivir for COVID-19 patients, since it doesn’t seem to boost their chances of survival

The FDA approved remdesivir as a treatment for severe COVID-19 cases last month, after granting emergency authorization in May. But on Thursday, the World Health Organization announced it will not recommend the drug’s use for COVID-19 patients. “There is currently no evidence that it improves survival or the need for ventilation,” the organization said. Visit…Continue Reading

FDA Approves Remdesivir, First Treatment for COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) approved remdesivir (Veklury) today as a treatment for hospitalized COVID-19 patients age 12 and up, making it the first and only approved treatment for the disease, according to a release from drug manufacturer Gilead…Continue Reading

Gilead's remdesivir gets US FDA approval for hospitalised Covid-19 patients

An ampule of Gilead Sciences remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020. — Pool pic via ReutersWASHINGTON, Oct 23 — The US Food and Drug Administration yesterday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalised with Covid-19, making it the…Continue Reading

Gilead’s Remdesivir is first coronavirus drug to get US Food and Drug Administration approval

A bottle containing Remdesivir is held by a health worker in Debrecen, Hungary on October 15. Photo: MTI via AP Antiviral therapy has already been widely used in hospitalised Covid-19 patients after being granted emergency-use authorisation earlier this year Remdesivir was given to Trump when US president was diagnosed with virus earlier this month Topic |  …Continue Reading

Remdesivir EUA Expanded; U.S. Hits 6 Million Mark; Nevada Reinfection Case

Note that some links may require registration or subscription. Remdesivir (Veklury) got emergency use authorization (EUA) from the FDA for treating moderate COVID-19, expanding on the prior EUA to now apply to all hospitalized COVID-19 patients, drugmaker Gilead announced. The unofficial U.S. tally of cases will pass the 6 million mark today, clocking in at…Continue Reading

World takes stock of Covid-19 drug remdesivir after U.S. snaps up supplies

By Sangmi Cha and Andreas Rinke and Alistair Smout 40m agoSeoul/Berlin/London – Some governments in Europe and Asia said on Wednesday they have enough of Gilead’s Covid-19 anti-viral remdesivir for now despite fears of shortages since the US drugmaker pledged most output to its home market for the next three months. The pharmaceutical company’s move…Continue Reading